129 related articles for article (PubMed ID: 33973470)
1. Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection.
Li Q; Chen Y; Xing S; Liao Q; Xiong B; Wang Y; Lu W; He S; Feng F; Liu W; Chen Y; Sun H
J Med Chem; 2021 May; 64(10):6856-6876. PubMed ID: 33973470
[TBL] [Abstract][Full Text] [Related]
2. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
3. Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
Jiang X; Zhang Z; Zuo J; Wu C; Zha L; Xu Y; Wang S; Shi J; Liu XH; Zhang J; Tang W
Eur J Med Chem; 2021 Nov; 223():113735. PubMed ID: 34371367
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease.
Chen Y; Zhang W; Li Q; Xie H; Xing S; Lu X; Lyu W; Xiong B; Wang Y; Qu W; Liu W; Chi H; Zhang X; Feng F; Sun H
Eur J Med Chem; 2024 Jun; 272():116463. PubMed ID: 38704944
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors.
Ghobadian R; Esfandyari R; Nadri H; Moradi A; Mahdavi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Edraki N; Sharifzadeh M; Amini M
Mol Divers; 2020 Feb; 24(1):211-223. PubMed ID: 30927138
[TBL] [Abstract][Full Text] [Related]
6. A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement.
Li Q; Xiong B; Wang Y; Lyu W; Xing S; Chen Y; Liao Q; He S; Feng F; Liu W; Chen Y; Sun H
Eur J Med Chem; 2022 Sep; 239():114510. PubMed ID: 35728508
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
Mo J; Yang H; Chen T; Li Q; Lin H; Feng F; Liu W; Qu W; Guo Q; Chi H; Chen Y; Sun H
Bioorg Chem; 2019 Dec; 93():103310. PubMed ID: 31586704
[TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease.
Liu D; Zhang H; Wang Y; Liu W; Yin G; Wang D; Li J; Shi T; Wang Z
Eur J Med Chem; 2022 Feb; 229():114044. PubMed ID: 34923430
[TBL] [Abstract][Full Text] [Related]
10. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
[TBL] [Abstract][Full Text] [Related]
11. Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening.
Lu T; Liu Y; Liu Y; Chen H; Han C; Feng X; Zhou H; Li Y
Future Med Chem; 2021 May; 13(9):769-784. PubMed ID: 33759552
[No Abstract] [Full Text] [Related]
12. Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment.
Montanari S; Mahmoud AM; Pruccoli L; Rabbito A; Naldi M; Petralla S; Moraleda I; Bartolini M; Monti B; Iriepa I; Belluti F; Gobbi S; Di Marzo V; Bisi A; Tarozzi A; Ligresti A; Rampa A
Eur J Med Chem; 2019 Sep; 178():243-258. PubMed ID: 31185414
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors.
Ghobadian R; Nadri H; Moradi A; Bukhari SNA; Mahdavi M; Asadi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Sharifzadeh M; Amini M
Bioorg Med Chem; 2018 Sep; 26(17):4952-4962. PubMed ID: 30190181
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine.
Jiang X; Liu C; Zou M; Xie H; Lin T; Lyu W; Xu J; Li Y; Feng F; Sun H; Liu W
Eur J Med Chem; 2021 Nov; 223():113663. PubMed ID: 34198150
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
16. Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition
Scheiner M; Sink A; Hoffmann M; Vrigneau C; Endres E; Carles A; Sotriffer C; Maurice T; Decker M
J Am Chem Soc; 2022 Feb; 144(7):3279-3284. PubMed ID: 35138833
[TBL] [Abstract][Full Text] [Related]
17. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.
Greig NH; Utsuki T; Ingram DK; Wang Y; Pepeu G; Scali C; Yu QS; Mamczarz J; Holloway HW; Giordano T; Chen D; Furukawa K; Sambamurti K; Brossi A; Lahiri DK
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17213-8. PubMed ID: 16275899
[TBL] [Abstract][Full Text] [Related]
18. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor.
Li Q; Xing S; Chen Y; Liao Q; Xiong B; He S; Lu W; Liu Y; Yang H; Li Q; Feng F; Liu W; Chen Y; Sun H
J Med Chem; 2020 Sep; 63(17):10030-10044. PubMed ID: 32787113
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
